Cost per responder for risankizumab vs secukinumab in patients with moderate-to-severe plaque psoriasis in Italy

by Paolo Gisondi, Francesco Loconsole, Paola Raimondo, Roberto Ravasio
Published 2021-09-01

Biologic Therapies in HIV-infected Patients with Psoriasis: An Italian Experience

by Federico Bardazzi, Michela Magnano, Anna Campanati, Francesco Loconsole, Antonio Carpentieri, Concetta Potenza, Nicoletta Bernardini, Vito Di Lernia, Carlo Carrera, Beatrice Raone, Annalisa Patrizi, Camilla Loi
Published 2017-05-01

Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME Study

by Marina Talamonti, Giovanna Malara, Ylenia Natalini, Federico Bardazzi, Andrea Conti, Andrea Chiricozzi, Cristina Mugheddu, Paolo Gisondi, Stefano Piaserico, Gianluca Pagnanelli, Paolo Amerio, Concetta Potenza, Franca Cantoresi, Maria Concetta Fargnoli, Anna Balato, Francesco Loconsole, Annamaria Offidani, Claudio Bonifati, Francesca Prignano, Marta Bartezaghi, Alice Rausa, Elisabetta Aloisi, Roberto Orsenigo, Antonio Costanzo
Published 2021-03-01